Colgate-Palmolive Company CL reported third-quarter FY23 sales growth of 10.5% year-on-year to $4.915 billion, beating the analyst consensus estimate of $4.814 billion.
Organic sales increased by 9%. Total Oral, Personal, and Home Care net sales increased by 7.6% to $3.85 billion.
Non-GAAP EPS of $0.86 beat the analyst consensus of $0.80.
Gross profit was $2.88 billion, while the margin expanded 130 basis points to 58.5%.
Selling, general and administrative expenses rose 11.5% to $1.8 billion.
Operating margin contracted 40 basis points to 20.9%, and operating income for the quarter increased 8.7% to $1.03 billion.
The company held $951 million in cash and equivalents as of September 30, 2023. Net cash provided by operations for nine months totaled $2.609 billion.
Outlook: Colgate sees FY23 net sales growth of 6%-8% (prior view 5% - 8%). The company now expects organic sales growth of 7%-8% (prior view 5% - 7%).
On a non-GAAP basis, the company still expects gross profit margin expansion and increased advertising investment, and the company now expects high-single-digits EPS growth (prior view high end of mid-single-digits).
Price Action: CL shares are trading higher by 0.88% at $73.73 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
